文献速递青光眼

METTL23变异与正常眼压性青光眼患者

METTL23 Variants and Patients With Normal-Tension Glaucoma.
PubMed 文献 · JAMA Ophthalmol · 2024-01-01

这项在爱荷华单中心开展的病例对照研究纳入331例正常眼压性青光眼(NTG)患者和362例无青光眼对照,检测METTL23致病变异。在NTG患者中发现3例(0.91%)携带可能致病的METTL23变异,但全部检出变异频率在两组间无统计学差异(1.5% vs 2.5%;P=0.27)。作者认为METTL23致病变异与NTG相关,约见于1%的NTG病例。

要点

  • 在331例NTG患者中检出3例(0.91%)携带可能致病的METTL23变异(p.Ala7Val、p.Pro22Arg、p.Arg63Trp)。
  • 全部检出变异频率在NTG组与对照组间无统计学差异(1.5% vs 2.5%;P=0.27)。
  • 作者认为METTL23致病变异约见于1%的NTG病例,频率与其他已知NTG基因相似。

核心结论

  • 本研究提供证据表明METTL23致病变异与正常眼压性青光眼(NTG)相关。
  • 在三级医疗中心的NTG队列中,致病变异约见于1%的NTG病例,频率与已知NTG基因OPTN、TBK1和MYOC相似。
  • 作者认为METTL23致病变异可能参与与较低眼压下发生的青光眼相关的生物学通路。

研究设计与样本

  • 本研究为病例对照研究,在爱荷华州一家三级医疗中心开展,时间为1997年1月至2024年1月,分析时间为2023年1月至2024年1月。
  • 从爱荷华大学诊所纳入331例NTG患者和362例无青光眼对照个体。
  • 排除有外伤史、使用类固醇、色素播散综合征特征、剥脱综合征或MYOC、TBK1、OPTN致病变异的患者。

主要发现

  • NTG组331例(平均[SD]年龄68.0[11.7]岁;女性228例[68.9%],男性103例[31.1%]),对照组362例(平均[SD]年龄64.5[12.6]岁;女性207例[57.2%],男性155例[42.8%])。
  • 在NTG患者中检出5例次4种独特METTL23变异。
  • p.Ala7Val、p.Pro22Arg和p.Arg63Trp三种变异被判定为可能致病,见于3例(0.91%)NTG患者。
  • 全部检出变异经突变负荷分析或逻辑回归评估,频率在NTG组与对照组间无统计学差异(1.5% vs 2.5%;P=0.27)。

关键数值与推荐

  • p.Ala7Val、p.Pro22Arg和p.Arg63Trp被判定为可能致病的METTL23变异。
  • NTG患者中可能致病METTL23变异检出率为0.91%(3例)。
  • 全部检出变异频率NTG组1.5% vs 对照组2.5%(P=0.27),无统计学差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: This research confirms and further establishes that pathogenic variants in a fourth gene, METTL23, are associated with autosomal dominant normal-tension glaucoma (NTG). OBJECTIVE: To determine the frequency of glaucoma-causing pathogenic variants in the METTL23 gene in a cohort of patients with NTG from Iowa. DESIGN, SETTING, AND PARTICIPANTS: This case-control study took place at a single tertiary care center in Iowa from January 1997 to January 2024, with analysis occurring between January 2023 and January 2024. Two groups of participants were enrolled from the University of Iowa clinics: 331 patients with NTG and 362 control individuals without glaucoma. Patients with a history of trauma; steroid use; stigmata of pigment dispersion syndrome; exfoliation syndrome; or pathogenic variants in MYOC, TBK1, or OPTN were also excluded. MAIN OUTCOMES AND MEASURES: Detection of an enrichment of METTL23 pathogenic variants in individuals with NTG compared with control individuals without glaucoma. RESULTS: The study included 331 patients with NTG (mean [SD] age, 68.0 [11.7] years; 228 [68.9%] female and 103 [31.1%] male) and 362 control individuals without glaucoma (mean [SD] age, 64.5 [12.6] years; 207 [57.2%] female and 155 [42.8%] male). There were 5 detected instances of 4 unique METTL23 pathogenic variants in patients with NTG. Three METTL23 variants-p.Ala7Val, p.Pro22Arg, and p.Arg63Trp-were judged to be likely pathogenic and were detected in 3 patients (0.91%) with NTG. However, when all detected variants were evaluated with either mutation burden analysis or logistic regression, their frequency was not statistically higher in individuals with NTG than in control individuals without glaucoma (1.5% vs 2.5%; P = .27). CONCLUSION AND RELEVANCE: This investigation provides evidence that pathogenic variants in METTL23 are associated with NTG. Within an NTG cohort at a tertiary care center, pathogenic variants were associated with approximately 1% of NTG cases, a frequency similar to that of other known normal-tension glaucoma genes, including optineurin (OPTN), TANK-binding kinase 1 (TBK1), and myocilin (MYOC). The findings suggest that METTL23 pathogenic variants are likely involved in a biologic pathway that is associated with glaucoma that occurs at lower intraocular pressures.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Scheetz TE, Tollefson MR, Roos BR, et al. METTL23 Variants and Patients With Normal-Tension Glaucoma. JAMA Ophthalmol. 2024. PMID: 39325437. doi:10.1001/jamaophthalmol.2024.3829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。